|
The case for upfront HLA-matched unrelated donor HCT as a curative option for adult acquired severe aplastic anemia: Upfront MUD HCT for adult severe aplastic anemia
|
May 2019
|
Biology of Blood and Marrow Transplantation: Journal of the American Society of Blood and Marrow Transplantation
|
aplastic anemia
|
|
Emerging Therapeutics for the Control of Chronic Graft-versus-Host Disease
|
Jan 2018
|
Biology of Blood and Marrow Transportation
|
graft versus host disease (GVHD)
|
|
Diagnosis of paroxysmal nocturnal hemoglobinuria in peripheral blood and bone marrow with six-color flow cytometry.
|
Feb 2012
|
Biomark Med
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes
|
Oct 2016
|
Biomed Pharmacother
|
myelodysplastic syndromes (MDS)
|
|
The myelodysplastic syndrome as a prototypical epigenetic disease.
|
May 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
|
Jul 2020
|
Blood
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
|
Aug 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Eltrombopag mobilizes iron in patients with aplastic anemia
|
Apr 2018
|
Blood
|
aplastic anemia
|
|
Thrombosis in paroxysmal nocturnal hemoglobinuria.
|
Apr 2013
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
May 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
